title: Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4.
abstract: The solution structure of the tumor suppressor p16INK4A has been determined by NMR, and important recognition regions of both cdk4 and p16INK4A have been identified. The tertiary structure of p16INK4A contains four helix-turn-helix motifs linked by three loops. Twelve tumorigenic mutants of p16INK4A have been constructed and analyzed for their structure and activity, and new mutants have been designed rationally. A fragment of 58 residues at the N terminus of cdk4 important for p16INK4A binding has been identified. The importance of this region was further verified by mutational analysis of cdk4. These results and docking experiments have been used to assess possible modes of binding between p16INK4A and cdk4.
authors.affiliation: Department of Chemistry, Ohio State University, Columbus 43210, USA.
authors.forename: I J
authors.initials: IJ
authors.lastname: Byeon
authors.forename: J
authors.initials: J
authors.lastname: Li
authors.forename: K
authors.initials: K
authors.lastname: Ericson
authors.forename: T L
authors.initials: TL
authors.lastname: Selby
authors.forename: A
authors.initials: A
authors.lastname: Tevelev
authors.forename: H J
authors.initials: HJ
authors.lastname: Kim
authors.forename: P
authors.initials: P
authors.lastname: O'Maille
authors.forename: M D
authors.initials: MD
authors.lastname: Tsai
mesh_terms: D001665:Binding Sites / Q000502:physiology; D015197:Carcinogenicity Tests; D051358:Cyclin-Dependent Kinase 4; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D018844:Cyclin-Dependent Kinases / Q000737:chemistry / Q000378:metabolism*; D004926:Escherichia coli; D006801:Humans; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D017354:Point Mutation / Q000502:physiology; D011485:Protein Binding / Q000502:physiology; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D011518:Proto-Oncogene Proteins; D017386:Sequence Homology, Amino Acid; D012995:Solubility
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; D011518:Proto-Oncogene Proteins; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases